Source document or public record
FDA 510(k) K193397 — ADVIA Centaur® Digoxin assay
FDA 510(k) index record K193397. Device: ADVIA Centaur® Digoxin assay. Applicant as listed: Siemens Healthcare Diagnostics, Inc.. Decision date: 2021-07-16.
Source
"device_name": "ADVIA Centaur® Digoxin assay"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K193397.
Device name: ADVIA Centaur® Digoxin assay. Applicant as listed: Siemens Healthcare Diagnostics, Inc..
Decision date: 2021-07-16. Decision wording: Substantially Equivalent.
Product code: KXT. Regulation: 21 CFR 862.3320. Medical specialty: Clinical Toxicology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.